Catherine Parker

1.9k total citations
32 papers, 811 citations indexed

About

Catherine Parker is a scholar working on Pulmonary and Respiratory Medicine, Clinical Psychology and Oncology. According to data from OpenAlex, Catherine Parker has authored 32 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Clinical Psychology and 6 papers in Oncology. Recurrent topics in Catherine Parker's work include Prostate Cancer Treatment and Research (10 papers), Multiple Myeloma Research and Treatments (4 papers) and COVID-19 and Mental Health (3 papers). Catherine Parker is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Multiple Myeloma Research and Treatments (4 papers) and COVID-19 and Mental Health (3 papers). Catherine Parker collaborates with scholars based in United States, United Kingdom and New Zealand. Catherine Parker's co-authors include William L. Dahut, James L. Gulley, Philip M. Arlen, Seth M. Steinberg, Elizabeth C. Jones, Howard L. Parnes, James R. Wright, William D. Figg, Clara C. Chen and Yinong Liu and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Catherine Parker

29 papers receiving 755 citations

Peers

Catherine Parker
Marco Fornili Italy
Hee Sang Hwang South Korea
Peter K. H. Lau Australia
Anna R. Franklin United States
Daniel C. Moreira United States
Isabella C. Glitza United States
John T. Cole United States
Harshabad Singh United States
Ibtissam Youlyouz‐Marfak Morocco
Fernando Franco Spain
Marco Fornili Italy
Catherine Parker
Citations per year, relative to Catherine Parker Catherine Parker (= 1×) peers Marco Fornili

Countries citing papers authored by Catherine Parker

Since Specialization
Citations

This map shows the geographic impact of Catherine Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Parker more than expected).

Fields of papers citing papers by Catherine Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Parker. The network helps show where Catherine Parker may publish in the future.

Co-authorship network of co-authors of Catherine Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Parker. A scholar is included among the top collaborators of Catherine Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Parker. Catherine Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Catherine, et al.. (2025). Psychiatry Consultation Clinic: A Model that Improves Access to Care and Corresponds to Decreased Anxiety and Depressive Symptoms. Administration and Policy in Mental Health and Mental Health Services Research. 53(1). 38–46.
2.
Parker, Catherine, Daniel Shalev, Ian C. Hsu, et al.. (2020). Depression, Anxiety, and Acute Stress Disorder Among Patients Hospitalized With COVID-19: A Prospective Cohort Study. Journal of the Academy of Consultation-Liaison Psychiatry. 62(2). 211–219. 42 indexed citations
3.
Parker, Catherine, et al.. (2020). Peppermint Oil: Evaluating Efficacy on Nausea in Patients Receiving Chemotherapy in the Ambulatory Setting. Clinical journal of oncology nursing. 24(2). 160–164. 16 indexed citations
4.
Parker, Catherine, et al.. (2019). Lymphedema after treatment of breast cancer: a comprehensive review. 2019. 6 indexed citations
5.
6.
Sampson, Chris, et al.. (2018). A Low Cost Escharotomy Simulation Model for Residency Education. 3(3). 2 indexed citations
7.
Parker, Catherine, Heather Lin, Yu Shen, et al.. (2014). Effect of hormone receptor status and local treatment on overall survival for early-stage breast cancer.. Journal of Clinical Oncology. 32(26_suppl). 60–60.
8.
Parker, Catherine, et al.. (2013). Experiences of adolescents who are primary caregivers to their Acquired Immune Deficiency Syndrome (AIDS) afflicted parents in sub-Saharan Africa: a systematic review protocol. International Journal of Evidence-Based Healthcare. 11(5). 157–168. 2 indexed citations
9.
Parker, Catherine & Nancy Waltman. (2012). Reducing the Frequency and Severity of Migraine Headaches in the Workplace: Implementing Evidence-Based Interventions. Workplace Health & Safety. 60(1). 12–18. 10 indexed citations
10.
Parker, Catherine & Nancy Waltman. (2012). Reducing the Frequency and Severity of Migraine Headaches in the Workplace. Workplace Health & Safety. 60(1). 12–18. 6 indexed citations
11.
Parker, Catherine. (2011). Attitudes and Perceptions of Early Childcare Professionals in Community-Based Programs in Regard to Inclusion of Children with Disabilities. Aquila Digital Community (University of Southern Mississippi). 2 indexed citations
12.
Olmos, David, J. W. Clark, Daniel Brewer, et al.. (2011). An evaluation of blood mRNA expression array signatures derived from unsupervised analyses in the identification of prostate cancers with poor outcome.. Journal of Clinical Oncology. 29(15_suppl). 4577–4577. 1 indexed citations
13.
Parker, Catherine. (2010). 301 Ways to Use Social Media To Boost Your Marketing. Bulletin of Miscellaneous Information (Royal Gardens Kew). 20 indexed citations
14.
Bono, Johann S. de, G. Attard, Catherine Parker, et al.. (2008). Anti-tumor activity of abiraterone acetate (AA), a CYP17 inhibitor of androgen synthesis, in chemotherapy naive and docetaxel pre-treated castration resistant prostate cancer (CRPC). Journal of Clinical Oncology. 26(15_suppl). 5005–5005. 15 indexed citations
15.
Arlen, Philip M., James L. Gulley, Catherine Parker, et al.. (2006). A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.. Clinical Cancer Research. 12(4). 1260–1269. 216 indexed citations
16.
Tohnya, Tanyifor M., Sylvia S. W. Ng, William L. Dahut, et al.. (2004). A Phase I Study of Oral CC-5013(Lenalidomide, Revlimid™), a Thalidomide Derivative, in Patients with Refractory Metastatic Cancer. PubMed. 2(4). 241–243. 24 indexed citations
17.
Dahut, William L., James L. Gulley, Philip M. Arlen, et al.. (2004). Randomized Phase II Trial of Docetaxel Plus Thalidomide in Androgen-Independent Prostate Cancer. Journal of Clinical Oncology. 22(13). 2532–2539. 257 indexed citations
18.
Horne, McDonald K., William D. Figg, James L. Gulley, et al.. (2003). Increased Frequency of Venous Thromboembolism with the Combination of Docetaxel and Thalidomide in Patients with Metastatic Androgen‐Independent Prostate Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(3). 315–318. 33 indexed citations
19.
Figg, William D., James L. Gulley, Patricia Fernández, et al.. (2001). A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer. Seminars in Oncology. 28(4M). 62–66. 11 indexed citations
20.
Parker, Catherine & Harold Rode. (1999). Alteplase (Activase [registered sign] rt-PA) for acute ischemic stroke: special precautions for new indication. Canadian Medical Association Journal. 161(1). 73–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Fornili Breakdown of academic impact, for papers by Hee Sang Hwang Breakdown of academic impact, for papers by Peter K. H. Lau Breakdown of academic impact, for papers by Anna R. Franklin Breakdown of academic impact, for papers by Daniel C. Moreira Breakdown of academic impact, for papers by Isabella C. Glitza Breakdown of academic impact, for papers by John T. Cole Breakdown of academic impact, for papers by Harshabad Singh Breakdown of academic impact, for papers by Ibtissam Youlyouz‐Marfak Breakdown of academic impact, for papers by Fernando Franco
Rankless by CCL
2026